Tildrakizumab Data Reveals Significant Wellbeing Improvement in Patients With Plaque Psoriasis
Data presented in a poster presentation at the 2023 World Congress of Dermatology meeting in Singapore showed significant improvements to patient quality of life.
PMC48 Probiotic Strain Demonstrates Promise in Hyperpigmentation
Pediococcus acidilactici demonstrated significant clinical efficacy and potential in treating hyperpigmentation.
Eczema Associated With Heightened Risk of Peanut Allergy in Infants
Pediatric patients with moderate to severe eczema demonstrated an increased risk of experiencing the food allergy.
6 Months in Review: Vitiligo in the First Half of 2023
As we have surpassed the halfway mark of 2023, Dermatology Times is spotlighting vitiligo coverage and news from the first half of year.
Ruxolitinib Granted Marketing Authorization in United Kingdom
The authorization comes just over 2 months after the drug’s approval in the European Union.
Trained Immunity May Play a Role in the Pathogenesis of Vitiligo
Trained immunity may act as an enhancer and continuous trigger in the disease’s pathogenesis.
Combination Stem Cell Transplantation, Laser Therapy Efficacious in Vitiligo
The combination of therapies achieved significant efficacy, with researchers noting a higher cure rate than is evident in other therapies for the condition.
FDA Clears Vbeam Pulsed Dye Laser for Pediatric Port Wine Stains, Hemangiomas
The device is now the first of its kind to become available to pediatric patients.
Discussing Evolving Research and Treatment Options in Plaque Psoriasis
Five expert dermatology clinicians discuss the changing landscape of plaque psoriasis treatments and research for adult patients.
Recap From the 2023 SDPA Annual Summer Dermatology Conference
If you weren’t able to attend the 2023 Society of Dermatology Physician Assistants (SDPA) Annual Summer Dermatology Conference or want to review our latest coverage and interviews, our full recap has you covered.
POLL: What Did You Take Away From SDPA Summer 2023?
Click here to answer today's poll.
SDPA Annual Summer Dermatology Conference Recap: Day 4
Catch up on coverage from the fourth and final day of the 2023 SDPA Annual Summer Dermatology Conference.
Photo Gallery: SDPA Annual Summer Dermatology Conference 2023
Want to reminisce on your time on Boston? View our conference photo gallery below.
Looking Ahead to the Future of Dermatology
As SDPA summer sessions have concluded, Arash Mostaghimi, MD, MPA, MPH, delves into what lies ahead in the dermatology industry—including the importance of collaboration between physicians and PAs.
The Future of Non-Invasive Skin Cancer Removal
Orit Markowitz, MD, discusses the future of non-invasive lasers in removing skin cancer and cancerous lesions, ultimately allowing patients to leave the practice without a bandaid.
Jane Mast, PhD, DMSc, MPAS: Empathy in the Patient Journey With HS
Jane Mast, PhD, DMSc, MPAS, discusses empathetic care in hidradenitis suppurativa and the importance of supporting patients with HS in every step of their journey with the condition.
Arash Mostaghimi, MD, MPA, MPH: Pearls in Dermatopathology and Alopecia
Arash Mostaghimi, MD, MPA, MPH, provides a comprehensive overview of his SDPA conference sessions, "Understanding the Pathology Report and Basic Biopsies," "Beyond the H&E," and "Alopecia: Treating Challenging Cases."
Dupilumab Improved Itch and Pain in Adults With Prurigo Nodularis
The drug also demonstrated efficacy in improving sleep quality and reducing sleep disruption.
Advances and Educational Opportunities to Improve Vitiligo Outcomes
In recognition of World Vitiligo Day, the Dermatology Times team is spotlighting advances and educational opportunities for the condition.
SDPA Annual Summer Dermatology Conference Recap: Day 3
Catch up on coverage from the third day of the 2023 SDPA Annual Summer Dermatology Conference.
Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD
Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCE
Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Recognizing and Treating Hidradenitis Suppurativa With Joslyn Kirby, MD
Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.
Abrocitinib Did Not Impact Immune Responses to Vaccination in Adolescents With Atopic Dermatitis
A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.
Conservative Imputation Method Efficacious in Moderate-to-Severe Hidradenitis Suppurativa
With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.
SDPA Annual Summer Dermatology Conference Recap: Day 2
Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.
Dupilumab Efficacious in Urticaria Symptom, Quality of Life Improvement
Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.
Renata Block, MMS, PA-C, Discusses the Role of the Dermatology PA Foundation in Supporting Physician Assistants
Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.
Tapinarof Demonstrates Efficacy in Patient With Nonulcerated Necrobiosis Lipoidica
In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.
John Barbieri, MD, MBA, FAAD: Aligning Treatments With Patients' Experiences
John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"
2 Clarke Drive Cranbury, NJ 08512